Xeris Biopharma Holdings, Inc. (XERS)
9.10
+0.15
(+1.68%)
USD |
NASDAQ |
Sep 25, 14:14
Xeris Biopharma Holdings Cash from Operations (TTM) : 56.61M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 56.61M |
| March 31, 2026 | 48.53M |
| December 31, 2025 | 28.63M |
| September 30, 2025 | 10.56M |
| June 30, 2025 | -16.18M |
| March 31, 2025 | -26.71M |
| December 31, 2024 | -36.98M |
| September 30, 2024 | -32.67M |
| June 30, 2024 | -38.98M |
| March 31, 2024 | -42.37M |
| December 31, 2023 | -48.21M |
| September 30, 2023 | -70.61M |
| June 30, 2023 | -73.76M |
| March 31, 2023 | -80.62M |
| December 31, 2022 | -102.89M |
| September 30, 2022 | -115.72M |
| June 30, 2022 | -120.58M |
| March 31, 2022 | -119.99M |
| Date | Value |
|---|---|
| December 31, 2021 | -95.54M |
| September 30, 2021 | -77.46M |
| June 30, 2021 | -71.83M |
| March 31, 2021 | -75.57M |
| December 31, 2020 | -80.56M |
| September 30, 2020 | -99.26M |
| June 30, 2020 | -112.86M |
| March 31, 2020 | -112.14M |
| December 31, 2019 | -104.35M |
| September 30, 2019 | -93.11M |
| June 30, 2019 | -78.44M |
| March 31, 2019 | -69.63M |
| December 31, 2018 | -56.28M |
| September 30, 2018 | -47.04M |
| June 30, 2018 | -36.70M |
| March 31, 2018 | -28.95M |
| December 31, 2017 | -24.66M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Zevra Therapeutics, Inc. | 33.40M |
| Aclaris Therapeutics, Inc. | -62.06M |
| ANI Pharmaceuticals, Inc. | 189.47M |
| Corcept Therapeutics, Inc. | 109.70M |
| Veru, Inc. | -26.04M |